Previous preclinical and clinical studies have shown promising results, suggesting that MMP-9 and MMP-2 may predict ischemic stroke outcomes, including hemorrhagic transformation (HT) and cerebral infarction volume [34, 35]. The gene discussed is MMP2; the disease is hematocrit.